MedVi vs Mochi Health: Telehealth GLP-1 Comparison

MedVi vs Mochi Health: quick verdict. MedVi is best for those seeking a simple online path to compounded semaglutide with a $179 promotional first month and 24/7 certified medical support. Mochi Health is best for people who want live video visits with a doctor in about 5 minutes, broader medication options including compounded tirzepatide, and membership-plus-medication pricing starting from $99.

Start MedVi semaglutide at $179

How MedVi and Mochi Health differ at a glance

MedVi and Mochi Health both operate as telehealth platforms that prescribe compounded GLP-1 medications, but they differ markedly in pricing structure, visit format, medication options, and how they present regulatory and outcome information. The table below highlights the most distinctive supported differences.

Pricing and membership structure compared

MedVi highlights a winter promotional rate of $179 for the first month including fast, free shipping, with standalone months rising afterward and a three-month plan available at a stated total of $649. Mochi Health describes a membership-plus-medication price structure with membership starting from $99/month, promotional reductions including 50% off the first month via a code, and compounded medication prices listed separately starting as low as $60 for semaglutide and $90 for tirzepatide.

Clinical interaction and care delivery

MedVi uses a simple online intake and a licensed clinician review without in-person visits. Its materials note OpenLoop Health clinicians meet with individuals after checkout and retain prescribing discretion. Mochi Health emphasizes synchronous live video visits with a doctor typically bookable in about 5 minutes, allowing real-time discussion of history and treatment. Both platforms state prescriptions are at provider discretion and both supply 24/7 support.

Access MedVi telehealth intake

Medication range and regulatory considerations

Mochi Health explicitly lists multiple compounded options including semaglutide injections, a compounded semaglutide pill, and compounded tirzepatide, plus other compound innovations. MedVi competes on clinically dosed compounded semaglutide only and does not offer tirzepatide in the supplied evidence. Both providers clearly state that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality, and both note that prescriptions are subject to clinician review and discretion.

Outcomes, support, and limitations

MedVi presents self-reported data and notes variability in results, sharing that MEDVi patients typically report 1 to 2 pounds per week after 4 weeks under certain conditions, while emphasizing results vary and are not guaranteed. Mochi Health also cautions that individual results are not guaranteed and provides an illustrative estimated result based on self reported member averages. Neither provider offers a published guarantee of specific outcomes in the supplied evidence.

Which differences matter most

• Pricing model: MedVi promotes a low first-month promo for semaglutide; Mochi uses membership-plus-medication pricing with separate compound med prices and first-month discounts.
• Visit format: MedVi is fully online asynchronous intake and clinician review; Mochi provides live video visits with a doctor in about 5 minutes.
• Medication breadth: Mochi lists both compounded semaglutide and compounded tirzepatide and oral compound options; MedVi focuses on compounded semaglutide.
• Regulatory clarity: Both state compounded medications are not FDA approved and prescribing is subject to clinician review.

Conclusion: choose based on what you value

MedVi vs Mochi Health comes down to trade offs: choose MedVi if you want a straightforward, no-clinic online path to compounded semaglutide with a $179 promotional first month and 24/7 certified medical support. Choose Mochi Health if you want live video visits with a doctor in about 5 minutes, membership-plus-medication pricing starting from $99, or access to compounded tirzepatide and oral compound options. Both platforms require clinician review and note compounded medications are not FDA approved.

Choose MedVi if you want the simplest online intake and a promotional semaglutide start price of $179 and 24/7 certified support. Choose Mochi Health if you prioritize live video doctor visits, broader compounded medication options including tirzepatide, and membership pricing starting from $99.